TIDMABC
RNS Number : 8513C
ABCAM PLC
22 October 2020
Abcam plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF REGULATION (EU) NO 596/2014
Abcam Announces Pricing of Offering on NASDAQ
October 22, 2020, London - Abcam plc (AIM: ABC) ("Abcam"), a
global leader in the supply of life science research tools,
announces today the pricing of its offering of 8,945,218 American
Depositary Shares ("ADSs"), representing an aggregate of 8,945,218
ordinary shares, at a price of $17.50 per ADS, for aggregate
proceeds of approximately $156.5 million, before deducting
underwriting discounts and commissions. Each ADS offered represents
one ordinary share of Abcam. The ADSs are being offered in a
registered public offering in the United States (the
"Offering").
In addition, Abcam has granted the underwriters a 30-day option
to purchase up to an additional 1,341,782 ADSs on the same terms
and conditions.
The closing of the Offering is expected to occur on October 26,
2020, subject to customary closing conditions.
Abcam's ordinary shares are admitted to trading on the AIM
market of the London Stock Exchange under the symbol "ABC." The
ADSs have been approved for listing on the NASDAQ Global Market
("NASDAQ") and are expected to begin trading under the symbol
"ABCM" on October 22, 2020.
Morgan Stanley and BofA Securities are acting as the lead
book-running managers for the Offering. SVB Leerink is acting as a
book-running manager, and Lazard and William Blair are acting as
co-managers.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
October 21, 2020. The Offering is being made only by means of a
prospectus. When available, copies of the final prospectus relating
to and describing the terms of the Offering may be obtained from
the offices of Morgan Stanley, Attention: Prospectus Department,
180 Varick Street, 2nd Floor, New York, New York 10014; or from
BofA Securities, Attention: Prospectus Department, 200 North
College Street, 3rd Floor, Charlotte, North Carolina 28255-0001, or
by email at dg.prospectus_requests@bofa.com .
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of,
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of such state or
jurisdiction.
Forward Looking Statements
This press release contains forward-looking statements. All
statements contained in this press release that do not relate to
matters of historical fact should be considered forward-looking
statements, including without limitation statements regarding
Abcam's plans to conduct the Offering.
These forward-looking statements are based on management's
current expectations. These statements are neither promises nor
guarantees but involve known and unknown risks, uncertainties and
other important factors that may cause Abcam's actual results,
performance or achievements to be materially different from its
expectations expressed or implied by the forward-looking
statements, including, but not limited to, the following: Abcam may
determine not to conduct a registered initial public offering in
the time frame that it currently expects or at all, due to a number
of potential important factors, including conditions in the U.S.
capital markets, negative global economic conditions, potential
negative developments in the COVID-19 pandemic, other negative
developments in Abcam's business or unfavorable legislative or
regulatory developments.
These and other important factors could cause actual results to
differ materially from those indicated by the forward-looking
statements made in this press release. Any such forward-looking
statements represent management's estimates as of the date of this
press release. While Abcam may elect to update such forward-looking
statements at some point in the future, Abcam disclaims any
obligation to do so, even if subsequent events cause its views to
change. These forward-looking statements should not be relied upon
as representing Abcam's views as of any date subsequent to the date
of this press release .
For readers in the European Economic Area and the United
Kingdom
There will be no public offer of the ADSs to the public in the
European Economic Area or the United Kingdom.
This communication , in so far as it constitutes an invitation
or inducement to enter into investment activity within the meaning
of section 21 of the Financial Services and Markets Act 2000 as
amended ("FSMA") in connection with the securities which are the
subject of the offering described in this press release or
otherwise, is only being directed at: (a) in the European Economic
Area (the "EEA"), persons who are qualified investors within the
meaning of Article 2(e) of Prospectus Regulation (EU) 2017/1129
(the "Prospectus Regulation") ("Qualified Investors"); and (b) in
the United Kingdom, Qualified Investors who are (i) persons who
fall within the definition of "Investment Professionals" in Article
19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005, as amended (the "Order"); or (ii) persons
who fall within Article 49(2)(a) to (d) ("High net worth companies,
unincorporated associations etc.") of the Order; or (c) persons to
whom it may otherwise be lawfully communicated (all such persons
referred to in (a), (b) and (c) above together being referred to as
"Relevant Persons").
The ADSs offered in the Offering are only available to, and any
invitation, offer or agreement to subscribe, purchase or otherwise
acquire such ADSs will be engaged in only with, in the EEA and the
United Kingdom, Relevant Persons. Any person who, in the EEA or the
United Kingdom, is not a Relevant Person should not act or rely on
this document or any of its contents. This communication does not
contain an offer or constitute any part of an offer to the public
within the meaning of sections 85 and 102B of FSMA or
otherwise.
For further information, please contact:
Abcam + 44 (0) 1223 696 000
James Staveley, Vice President, Investor Relations
Numis - Nominated Advisor & Joint Corporate Broker + 44 (0) 20 7260 1000
Garry Levin / Duncan Monteith / Huw Jeremy
J.P. Morgan Cazenove - Joint Corporate Broker + 44 (0) 20 7742 4000
James Mitford / Hemant Kapoor
Morgan Stanley - Joint Corporate Broker + 44 (0) 207 425 8000
Tom Perry / Luka Kezic
FTI Consulting + 44 (0) 20 3727 1000
Ben Atwell / Natalie Garland-Collins
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCPPGGAUUPUPGG
(END) Dow Jones Newswires
October 22, 2020 02:00 ET (06:00 GMT)
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024